Previous 10 | Next 10 |
- Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain - NanoVibronix partnering with Saralex Group for regulatory approval and global distribution ELMSFORD, NY / ACCESSWIRE / June 3, 2019 / NanoVibr...
NanoVibronix (NASDAQ: NAOV ) provides near term goals for 2019. More news on: NanoVibronix, Inc., Healthcare stocks news, Read more ...
ELMSFORD, NY / ACCESSWIRE / May 24, 2019 / NanoVibronix, Inc ., (NASDAQ: NAOV) , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the first quarter ended March 31, 2019. ...
Reports on Commercial Progress for both PainShield® and UroShield® ELMSFORD, NY / ACCESSWIRE / April 2, 2019 / NanoVibronix, Inc ., (NASDAQ: NAOV) , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, ...
Reimbursement aligned with AHIP and CMS initiatives to help combat the opioid epidemic ELMSFORD, NY / ACCESSWIRE / March 25, 2019 / NanoVibronix, Inc ., (NASDAQ: NAOV) , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) t...
ELMSFORD, NY / ACCESSWIRE / March 20, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV) , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has entered into an exclusive agreement with N.B.A. medica s.r.l...
ELMSFORD, NY / ACCESSWIRE / March 8, 2019 / NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing its proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that CEO Brian Murphy will present UroShield® at the Catheter-Associated U...
70% of patients using PainShield experienced complete resolution or significant improvement in symptoms without the use of opioids PainShield had no adverse events or complications and was deemed both safe and effective ELMSFORD, NY / ACCESSWIRE / March 7, 2019 / NanoVibronix,...
ELMSFORD, NY / ACCESSWIRE / February 4, 2019 / NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has launched a new website ( www.nanovibronix.com ) designed to...
55.2% improvement in baseline pain scores versus 2.3% for the control group 46.4% reduction in breakthrough pain medication, including opioids, versus 1.5% versus for the treatment group PainShield™ had no adverse events or complications and was deemed both safe and ef...
News, Short Squeeze, Breakout and More Instantly...
NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the University of Michigan will begin the pilot phase of its clinical tri...
NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has ent...
Distribution Partner, Delta Medical, Awarded a Five-Year Federal Supply Schedule Contract for PainShield by Department of Veterans Affairs NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShie...